A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis

NCT00938587 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: PF-04171327 10 mg
OTHER: Prednisone Placebo
DRUG: PF-04171327 25 mg
OTHER: Prednisone Placebo
DRUG: Prednisone 5 mg
OTHER: Placebo for PF-04171327
OTHER: Placebo
OTHER: Placebo for PF-04171327

Sponsor

Pfizer